Literature DB >> 29386422

[Quality Evaluation of Saposhnikoviae Radix (Differences between Wild-type and Cultivated Products)].

Masakazu Nishihara1, Keiji Nukui1, Yuko Osumi1, Hironori Shiota1.   

Abstract

Saposhnikoviae Radix ("Boufu") is an important crude drug used in Kampo formulation. It is extracted from wild-type plants. However, recently, extraction has become difficult because of a decrease in wild-type plants. Therefore, cultivated plants account for the majority of the market, from which the crude drug is extracted. However, the cultivation techniques used are not sufficient to obtain the desirable extracts. In this study, we compared the contents of the extract and the quantitative values of characteristic constituents obtained from wild-type and cultivated plants, and found a remarkable difference. Therefore, it is considered that these indicators play an important role in the establishment of better cultivation technology.

Keywords:  4′-O-glucosyl-5-O-methylvisamminol; Saposhnikovia Root and Rhizome; Saposhnikoviae Radix; cimifugin; prim-O-glucosyl cimifugin

Mesh:

Substances:

Year:  2018        PMID: 29386422     DOI: 10.1248/yakushi.17-00208

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  3 in total

1.  Simultaneous UHPLC/MS quantitative analysis and comparison of Saposhnikoviae radix constituents in cultivated, wild and commercial products.

Authors:  Hiroyuki Fuchino; Atsuyuki Hishida; Sayaka Murase; Nobuo Kawahara
Journal:  J Nat Med       Date:  2021-02-11       Impact factor: 2.343

2.  Metabolomic profiling of Saposhnikoviae Radix from Mongolia by LC-IT-TOF-MS/MS and multivariate statistical analysis.

Authors:  Zolboo Batsukh; Kazufumi Toume; Batkhuu Javzan; Kohei Kazuma; Shao-Qing Cai; Shigeki Hayashi; Nobuo Kawahara; Takuro Maruyama; Katsuko Komatsu
Journal:  J Nat Med       Date:  2019-10-01       Impact factor: 2.343

3.  Identification of Constituents and Exploring the Mechanism for Toutongning Capsule in the Treatment of Migraine.

Authors:  Xia Du; Zhibiao Di; Yang Liu; Wenbing Zhi; Yuan Liu; Hong Zhang; Feng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-15       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.